AstraZeneca’s MedImmune and 4D Molecular Therapeutics forged a collaboration to develop a gene therapy for chronic lung disease.
{iframe}https://www.biospace.com/article/medimmune-and-4d-molecular-therapeutics-collaborate-on-aav-gene-therapy-for-lung-disease/{/iframe}